New understanding about the pathophysiology of the condition, along with new clinical trial endpoints for approval, have ...

Dr Arturo Loaiza-Bonilla examines the gap between ivermectin’s lab data and clinical reality, offering a guide to debunking ...

Bonilla examines the gap between ivermectin’s lab data and clinical reality, offering a guide to debunking ‘miracle cure’ ...

Compared with the recommended 4- to 7-day antibiotic course, a 1-day regimen achieved similar clinical cure rates, with no ...

A history of adequately treated syphilis before pregnancy is associated with more than a 100-fold increase in congenital syphilis risk.

Positive phase 3 findings may reshape Lyme disease prevention among people with frequent tick exposure across endemic regions ...

The new exoskeleton technology combines biomechanics, sensors, and patient feedback to support gait training and ...

This research may be helpful as primary care providers (PCPs) work with patients in managing blood sugar and cardiovascular ...

Giredestrant plus everolimus does not increase treatment burden in advanced breast cancer, new safety and patient-reported outcome data from the evERA BC trial show.

Jehovah’s Witnesses now allow members to choose to use their own blood in some procedures, reigniting debate over bloodless ...

The reasons for the disparities are not clear, but they point to the complexity of the diagnosis and the different ways ...

A new seven factor score predicts long term mortality after ST-elevation myocardial infarction in patients who undergo ...